<DOC>
	<DOC>NCT01064882</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of bimatoprost ophthalmic solution 0.005% or 0.015% compared with bimatoprost ophthalmic solution 0.03% once-daily application to the upper eyelid margins in increasing eyelash prominence</brief_summary>
	<brief_title>Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence</brief_title>
	<detailed_description />
	<mesh_term>Hypotrichosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Female Caucasians between 30 and 55 years of age, with hypotrichosis (inadequate or not enough) of the eyelashes Eyelash prominence assessment of minimal or moderate Any eye disease or abnormality Any permanent eyeliner or eyelash implants of any kind Any ocular surgery, semipermanent eyelash tint, or eyelash extension application during the 3 months prior to study entry Any use of prescription eyelash growth products Any use of over the counter eyelash growth products during the 6 months prior to baseline Any use of treatments that may affect hair growth during the 6 months prior to baseline</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>